about
Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of CholangiocarcinomaThe significance of genetics for cholangiocarcinoma developmentMicroRNA-26a promotes cholangiocarcinoma growth by activating β-cateninA multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu.Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.Estrogens and the pathophysiology of the biliary treeChemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model.Recent advances in the regulation of cholangiocarcinoma growthMolecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass SpectrometryCyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.Current status of photodynamic therapy for bile duct cancer.Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes.Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinomaMicrosomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry.Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinomaComparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of InvasionInhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaMolecular Targets in Biliary Carcinogenesis and Implications for Therapy.Effect of vascular endothelial growth factor-C expression on lymph node metastasis in human cholangiocarcinomaTGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma.Idiopathic benign biliary strictures in surgically resected patients with presumed cholangiocarcinomaSystematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach.Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion.The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma CellsSustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell LineCholestatic liver disease. Recognizing the clinical signs.EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence.Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma
P2860
Q24814067-4A4ADC6F-8BDB-4AC6-B1BB-C45A3C4CAF18Q26784091-1EC59DD2-F7AA-4EE5-8B94-61F0093921F5Q26865749-9619B14E-65A9-49AD-A172-209BAF3078C5Q28263940-42EFBE7F-3BA5-4776-9024-8CB0FE0CA163Q33391729-EC7D52AA-E39F-4825-B9D9-B64F5DE42824Q33575284-B9056B2D-DE13-4669-98C0-9D95358A1BDBQ33824237-0F4B2C97-47DB-4C1D-BECA-DC4448D3EB78Q33866800-66512A78-BAFF-4F65-A0A4-E3DC43E48689Q33977095-718C9B7F-857E-4E5E-AE4E-51EDC4F5BA1FQ33994814-61D473AF-8BEE-41D1-AB89-E4CE5FC41264Q34000409-D44ECED1-066F-41C4-B7CF-FCBAD524AE48Q34224792-CDF51338-9ACB-4F27-AA5A-4CFF80587B86Q34377996-B5E1D047-45D6-4A22-8F52-C417D00939AAQ34414026-DDF6611E-0B47-45DA-AF34-67B6A031F176Q34461850-28C97A60-D8A7-4E64-8EDE-4CD4C00918D7Q34504973-D8B5D5EE-8F76-4142-A2DE-99AE3871F0FBQ34592228-9DE372CE-0441-46F8-8298-70AB92A916D0Q34881846-4AC9C7B4-E568-41FC-AD7A-BD6EBF3EFBE6Q34882042-2FBF8D26-D905-465F-8C52-3CEA6FF0C974Q34904867-4034A81F-9E9D-4FB7-9D9B-B63EDACC3A9FQ35010217-96629079-78A8-41C2-B946-0FD2E68A91CBQ35028164-8D01E8B4-A5D5-44C6-83D6-2D6F8B2FCDE2Q35134122-834732E7-16D6-4281-8A92-883EBBED670BQ35190775-7D79B16A-B9FB-4597-97B0-E425F9E66CEBQ35222052-D07076C0-4CE8-4B41-9C01-812BB6E02549Q35591343-CECFE7B9-58FC-4918-8DD0-5EB2EC0973FCQ35629462-76BB12AC-4634-44E5-A5F7-5B24025DDF1DQ35820533-36A92A8A-DD46-4769-A824-21366303DADFQ35870206-170B66BD-C823-4220-8956-62FA56B5D6B7Q35885365-349F5990-0F51-4DE7-B49B-C1D551F1FDC5Q36094605-402C0A5A-F1C7-4C96-9028-B02F39C63EC0Q36151669-4891CA27-5C60-4D0D-BB06-23CF3E07F0EFQ36177918-7C7BA064-3C26-4A82-AB1F-4779205C86B6Q36190329-A14D8ABB-87AA-4AA3-868B-0BAB5BA595AAQ36388133-52541B8A-0E5E-4881-BBE4-908B04B4D99DQ36388792-681F4904-AFED-48E6-A00C-8687C7367705Q36407288-1EF1A629-DF7B-4228-BA90-FC973D0BB79DQ36567737-E21D323F-9F85-4C06-B9A0-7F61DA72F352Q36793822-C6974B9E-267F-4F07-AF9D-9BC21CA4E30FQ37064043-B6C4857E-9455-484B-A8E3-16BEE2823B20
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cholangiocarcinoma: current concepts and insights.
@ast
Cholangiocarcinoma: current concepts and insights.
@en
type
label
Cholangiocarcinoma: current concepts and insights.
@ast
Cholangiocarcinoma: current concepts and insights.
@en
prefLabel
Cholangiocarcinoma: current concepts and insights.
@ast
Cholangiocarcinoma: current concepts and insights.
@en
P356
P1433
P1476
Cholangiocarcinoma: current concepts and insights.
@en
P304
P356
10.1053/JHEP.2003.50200
P407
P577
2003-05-01T00:00:00Z